{"id":150696,"date":"2026-11-18T08:00:41","date_gmt":"2026-11-18T02:30:41","guid":{"rendered":"https:\/\/www.bananaip.com\/intellepedia\/?p=150696"},"modified":"2026-11-15T11:13:52","modified_gmt":"2026-11-15T05:43:52","slug":"copied-pharma-website-copyright-injunction","status":"publish","type":"post","link":"https:\/\/www.bananaip.com\/intellepedia\/copied-pharma-website-copyright-injunction\/","title":{"rendered":"Not So Fine a Cure: Copied Pharma Website Draws Copyright Injunction"},"content":{"rendered":"<h2>Background<\/h2>\n<h3>Website Copyright Dispute<\/h3>\n<p>Finecure Pharmaceuticals Limited (Finecure) is a pharmaceutical and nutraceutical manufacturer that has been in business since 1996 under the brand name FINECURE. Over the years, it has grown to offer more than 250 formulations, sold under brand names such as FINEMOX, FINETRIAX, BPGARD, CAROSU, RABIFINE, PEPCARE, MYNERVE and MENUVIT, and it has a presence in more than 20 international markets.<\/p>\n<p>To present its business and products, Finecure has maintained the website www.finecurepharma.com since 2005. The website was created by Tristate Technology LLP on Finecure&#8217;s instructions and under its control, and by a letter dated 7 September 2026, the agency assigned all rights in the website, including copyright, to Finecure. Apart from this, the product artwork and other original elements on the website were created by Finecure&#8217;s employees in the course of their employment. Finecure also holds Copyright Registration No. A\/79409\/2007, covering the artistic and literary works comprised in the website, such as its text, product descriptions, photographs, graphics, layout, colour scheme and overall design.<\/p>\n<p>In the fourth week of October 2026, Finecure came across the website www.cubitlifesciences.com, which had been registered on 13 August 2026 by Defendant No. 1. The website was connected with Cubit Lifesciences LLP, a pharmaceutical business based in Gujarat, whose designated partners were also made defendants. Finecure immediately recorded the website on 27 October 2026 and preserved the hash value of the recording. It then filed a suit before the Delhi High Court seeking a permanent injunction against infringement of its copyright, along with an application for interim relief.<\/p>\n<h2>Questions Before the Court<\/h2>\n<ul>\n<li>Whether Finecure had made out a prima facie case of copyright infringement in respect of its website content.<\/li>\n<li>Whether the balance of convenience was in favour of Finecure, and whether it would suffer irreparable injury if an interim injunction was not granted.<\/li>\n<\/ul>\n<h2>Arguments Presented By the Plaintiff<\/h2>\n<p>As the order was passed at the first hearing, only Finecure&#8217;s submissions were recorded. Finecure argued that:<\/p>\n<ul>\n<li>It owned the copyright in its website content, through the registration, the assignment from the agency, and the work of its employees, and each webpage carried a copyright notice in its name.<\/li>\n<li>The defendants knew Finecure and its business well, since Defendant No. 3 had entered into a third party manufacturing agreement with Finecure in 2014, under which Finecure manufactured products that Defendant No. 3 marketed under its own brand until 2018.<\/li>\n<li>The impugned website reproduced Finecure&#8217;s corporate particulars, such as its CIN, registered office address and year of incorporation, and also referred to Finecure repeatedly.<\/li>\n<li>The defendants adopted Finecure&#8217;s tagline &#8220;Making Lives Healthier&#8221; as their own mission, and displayed the packaging and artwork of Finecure&#8217;s products, some of which were later removed.<\/li>\n<li>The text, layout and design of Finecure&#8217;s website, including its statistics, manufacturing content, news posts and header and footer design, were reproduced almost verbatim.<\/li>\n<li>The defendants presented Finecure&#8217;s awards, manufacturing credentials and capacities as their own, and used them to solicit business, which amounted to infringement under Sections 14 and 51 of the Copyright Act, 1957.<\/li>\n<\/ul>\n<h2>Court&#8217;s Analysis<\/h2>\n<h3>Prima Facie Case of Copyright Infringement<\/h3>\n<p>The Court first considered whether Finecure had shown that it owned the copyright in its website. On this aspect, it found that the assignment letter dated 7 September 2026 and Copyright Registration No. A\/79409\/2007 lent prima facie support to Finecure&#8217;s claim.<\/p>\n<p>Having accepted Finecure&#8217;s claim of ownership, the Court compared the two websites. According to the Court, the comparison revealed substantial reproduction of Finecure&#8217;s original content, including its text, photographs, graphics and product packaging artwork. The impugned website went further, as it reproduced Finecure&#8217;s corporate identity, referred to Finecure by name, adopted the tagline &#8220;Making Lives Healthier&#8221; as its own, and displayed photographs of Finecure&#8217;s product packs. It also reproduced the layout and design of Finecure&#8217;s website, and presented Finecure&#8217;s business credentials and achievements as those of the defendants.<\/p>\n<p>Rather than examining each of these instances in isolation, the Court looked at them together. Taken cumulatively, the instances indicated unauthorised reproduction and use of Finecure&#8217;s copyrighted works, and the Court therefore held that Finecure had made out a prima facie case of copyright infringement.<\/p>\n<h3>Balance of Convenience and Irreparable Injury<\/h3>\n<p>The Court then held that the balance of convenience was in favour of Finecure, as the defendants had not shown any right or authorisation to use its copyrighted works. If the defendants were allowed to continue, they would be able to commercially exploit Finecure&#8217;s works and harm its commercial interests and reputation, whereas restraining them would cause them no legitimate prejudice. For the same reason, the Court found that the continued use could erode consumer trust and market credibility, which is an injury that money cannot adequately compensate.<\/p>\n<h2>Findings<\/h2>\n<p>The findings of the Court are as follows:<\/p>\n<ul>\n<li>The assignment letter and the copyright registration lent prima facie support to Finecure&#8217;s claim of copyright in its website content.<\/li>\n<li>The impugned website substantially reproduced Finecure&#8217;s text, photographs, graphics, product packaging artwork, layout and design, and adopted its tagline as its own.<\/li>\n<li>Taken cumulatively, these instances made out a prima facie case of copyright infringement.<\/li>\n<li>The balance of convenience was in favour of Finecure, as the defendants had shown no right or authorisation to use the works.<\/li>\n<li>Continued use of the works would cause Finecure irreparable injury to its reputation and brand equity.<\/li>\n<\/ul>\n<p>Based on these findings, the Court restrained the defendants and those acting on their behalf from uploading, reproducing, publishing or communicating to the public Finecure&#8217;s copyrighted works comprised in its website, including the contents and look and feel of the website. The defendants were given four weeks to file their reply after service of notice, and the matter was listed on 3 March 2027.<\/p>\n<h2>Relevant Paras<\/h2>\n<h3>Paragraph 25<\/h3>\n<blockquote><p>&#8220;The material placed on record, including the assignment letter dated 07.09.2026 and Copyright Registration No. A\/79409\/2007, lends prima facie support to the Plaintiff&#8217;s claim. A comparison of the Plaintiff&#8217;s Website with the Impugned Website reveals substantial reproduction of the Plaintiff&#8217;s original content, including its text, photographs, graphics and product packaging artwork. The Impugned Website also reproduces the Plaintiff&#8217;s corporate identity and particulars, repeatedly refers to the Plaintiff by name, adopts its tagline &#8220;Making Lives Healthier&#8221; as its own, and displays photographs of the Plaintiff&#8217;s product packs bearing its original artistic work. Further, the Impugned Website reproduces substantial portions of the Plaintiff&#8217;s website content, including its layout and design, and represents the Plaintiff&#8217;s business credentials and achievements as those of the Defendants. These instances, taken cumulatively, prima facie indicate unauthorised reproduction and use of the Plaintiff&#8217;s Copyrighted Works. Accordingly, the Plaintiff has made out a prima facie case of copyright infringement.&#8221;<\/p><\/blockquote>\n<h3>Paragraph 26<\/h3>\n<blockquote><p>&#8220;The balance of convenience lies in favour of the Plaintiff, as the Defendants have not demonstrated right or authorisation to use the Plaintiff&#8217;s Copyrighted Works. Permitting Defendants continued use would enable unauthorised commercial exploitation of the Plaintiff&#8217;s Copyrighted Works and adversely affect its commercial interests and reputation. Conversely, restraining such use would cause no legitimate prejudice to the Defendants. The Plaintiff would suffer irreparable injury as the Defendants&#8217; continued unauthorised use may expose its reputation and brand equity to harm, resulting in erosion of consumer trust and market credibility, which cannot be adequately compensated by monetary damages.&#8221;<\/p><\/blockquote>\n<h2>Case Citation<\/h2>\n<p>Finecure Pharmaceuticals Limited v. Mr Nilesh Jain and Ors., CS(COMM) 1207\/2026, Delhi High Court, order dated 5 November 2026, Indian Kanoon, available at <a href=\"http:\/\/indiankanoon.org\/doc\/132694472\/\" target=\"_blank\" rel=\"noopener\">http:\/\/indiankanoon.org\/doc\/132694472\/<\/a> (visited 12 November 2026).<\/p>\n<h2>Disclaimer<\/h2>\n<p>This case blog is based on the author&#8217;s understanding of the judgment. Understandings and opinions of others may differ. An AI application was used to generate parts of this case blog based on user inputs and prompts.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the case of Finecure Pharmaceuticals Limited v. Mr Nilesh Jain and Ors., a pharmaceutical company found that a newly registered website had copied its website text, layout, product artwork and its tagline &#8220;Making Lives Healthier&#8221;. The Delhi High Court held that these instances, taken together, showed prima facie copyright infringement, and granted an interim injunction protecting the content and look and feel of the company&#8217;s website.<\/p>\n","protected":false},"author":3,"featured_media":150697,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"iawp_total_views":4,"footnotes":""},"categories":[3,5495,6],"tags":[31,13341,486,13340,4374,402],"class_list":["post-150696","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-copyrights","category-case-reviews","category-intellectual-property","tag-copyright-infringement","tag-cubit-lifesciences-llp","tag-delhi-high-court","tag-finecure-pharmaceuticals-limited","tag-interim-injunction","tag-website-content"],"_links":{"self":[{"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/posts\/150696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/comments?post=150696"}],"version-history":[{"count":3,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/posts\/150696\/revisions"}],"predecessor-version":[{"id":150707,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/posts\/150696\/revisions\/150707"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/media\/150697"}],"wp:attachment":[{"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/media?parent=150696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/categories?post=150696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bananaip.com\/intellepedia\/wp-json\/wp\/v2\/tags?post=150696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}